Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Corcept Therapeutics (CORT) SEC Filings & 10K Form

Corcept Therapeutics logo
$69.58 -0.15 (-0.22%)
Closing price 04:00 PM Eastern
Extended Trading
$69.74 +0.17 (+0.24%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Corcept Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/26/2025
5:56 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2025
9:58 AM		Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
6:22 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
6:19 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
9:20 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025
6:17 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:47 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:51 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:51 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
12:05 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:00 AM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:11 AM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
10:25 AM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/21/2025
6:10 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:10 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:11 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
6:14 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
7:12 PM		BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
07/14/2025
3:36 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
7:05 AM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
11:21 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
7:35 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:36 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:39 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:52 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:01 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:09 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
5:26 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:53 PM		Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:39 PM		Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:40 PM		Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:41 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:42 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM		Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM		Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:46 PM		Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:08 PM		BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
10:03 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025
7:32 PM		Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:32 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:33 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
An $8 trillion-dollar discovery 17,000 ft underwater (Ad)

A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel

See the name and ticker behind America’s $16 trillion resource push.
06/04/2025
7:34 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:41 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:57 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
1:31 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
12:59 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
1:25 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
6:35 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:13 PM		Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
1:29 PM		Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
1:32 PM		Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
12:40 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
4:51 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:40 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
7:20 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:33 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:26 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:28 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
2:52 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2025
6:41 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
6:09 AM		BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
4:58 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
9:07 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
7:01 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:08 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:20 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
2:13 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:23 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:00 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
7:05 AM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
5:55 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
7:30 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:30 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:54 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
10:02 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:15 PM		Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:53 PM		Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:58 PM		Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:34 PM		Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:38 PM		Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM		Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:59 PM		Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:47 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:37 AM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:18 AM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:18 PM		Corcept Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
3:06 PM		Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
An $8 trillion-dollar discovery 17,000 ft underwater (Ad)

A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel

See the name and ticker behind America’s $16 trillion resource push.
02/21/2025
4:23 PM		Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:08 PM		BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
3:40 PM		BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2025
7:20 PM		Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:26 PM		Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
10:36 AM		Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:33 PM		Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:17 PM		Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
3:14 PM		Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CORT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Trump’s national nightmare is here
AI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...
Porter & Company | Sponsoredtc pixel